The Cholesterol-Virus Axis: From Pathogenic Mechanisms to Host-Directed Therapies

Cholesterol plays a vital role in cellular membranes and serves as a key signaling molecule, positioning itself at the intersection of viral infection and host immunity. Viruses from various families have developed advanced mechanisms to exploit host cholesterol metabolism, manipulating its synthesis, trafficking, and distribution to aid in their entry, replication, and egress. This review consolidates current insights into how viruses, such as coronaviruses, flaviviruses, and hepatitis viruses, commandeer cholesterol-rich membrane domains and biosynthetic pathways, including the SREBP cascade, to create environments conducive to their life cycles. In response, hosts have evolved countermeasures, utilizing interferon-stimulated genes like IFITM3 and CH25H, which produces the antiviral oxysterol 25-hydroxycholesterol, to disrupt cholesterol homeostasis and limit viral spread. We examine the clinical implications of this metabolic struggle, including dyslipidemia, steatosis, and insulin resistance linked to chronic infections like HCV and HIV. Finally, we assess the therapeutic potential of targeting the virus-cholesterol axis, considering the use of repurposed lipid-lowering drugs (e.g., statins, PCSK9 inhibitors) and novel host-directed therapies as broad-spectrum antiviral strategies. This review underscores cholesterol's dual role as both a crucial resource for viruses and a powerful component of the host's antiviral defense.

Authors

Publication Details

Journal
Preprints.org
Published
2026-11-17
DOI
https://doi.org/10.20944/preprints202611.1683.v1
Primary Topic
Cholesterol and Lipid Metabolism
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

The Cholesterol-Virus Axis: From Pathogenic Mechanisms to Host-Directed Therapies

Yuhan Zhao, Jing Sha, Wenyu Qiu, Haixu Xu
Preprints.org
Cholesterol and Lipid Metabolism
preprint

The Cholesterol-Virus Axis: From Pathogenic Mechanisms to Host-Directed Therapies

Yuhan Zhao, Jing Sha, Wenyu Qiu, Haixu Xu
preprint en

Abstract

Cholesterol plays a vital role in cellular membranes and serves as a key signaling molecule, positioning itself at the intersection of viral infection and host immunity. Viruses from various families have developed advanced mechanisms to exploit host cholesterol metabolism, manipulating its synthesis, trafficking, and distribution to aid in their entry, replication, and egress. This review consolidates current insights into how viruses, such as coronaviruses, flaviviruses, and hepatitis viruses, commandeer cholesterol-rich membrane domains and biosynthetic pathways, including the SREBP cascade, to create environments conducive to their life cycles. In response, hosts have evolved countermeasures, utilizing interferon-stimulated genes like IFITM3 and CH25H, which produces the antiviral oxysterol 25-hydroxycholesterol, to disrupt cholesterol homeostasis and limit viral spread. We examine the clinical implications of this metabolic struggle, including dyslipidemia, steatosis, and insulin resistance linked to chronic infections like HCV and HIV. Finally, we assess the therapeutic potential of targeting the virus-cholesterol axis, considering the use of repurposed lipid-lowering drugs (e.g., statins, PCSK9 inhibitors) and novel host-directed therapies as broad-spectrum antiviral strategies. This review underscores cholesterol's dual role as both a crucial resource for viruses and a powerful component of the host's antiviral defense.

Preprints.org
Good health and well-being
Cholesterol and Lipid Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon